EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 374 filers reported holding EXELIXIS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,203,000 | +2.3% | 75,000 | 0.0% | 0.06% | -8.8% |
| Q3 2022 | $1,176,000 | -24.7% | 75,000 | 0.0% | 0.07% | -25.3% |
| Q2 2022 | $1,562,000 | +65.6% | 75,000 | +44.8% | 0.09% | +213.8% |
| Q2 2021 | $943,000 | -37.2% | 51,779 | -22.1% | 0.03% | -32.6% |
| Q1 2021 | $1,501,000 | -61.2% | 66,460 | -66.2% | 0.04% | -94.4% |
| Q4 2018 | $3,870,000 | +118.4% | 196,755 | +96.8% | 0.77% | +107.2% |
| Q3 2018 | $1,772,000 | +100.0% | 100,000 | +150.0% | 0.37% | -28.7% |
| Q1 2018 | $886,000 | -63.6% | 40,000 | -50.0% | 0.52% | -48.6% |
| Q4 2017 | $2,432,000 | +98.4% | 80,000 | +58.1% | 1.02% | +183.6% |
| Q3 2017 | $1,226,000 | – | 50,600 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |